Biology Reference
In-Depth Information
kisspeptin-54 causes testicular degeneration in adult male rats. Am J Physiol Endocrinol
Metab 291:E1074-1082
50. Ramaswamy S, Seminara SB, Pohl CR, DiPietro MJ, Crowley WF Jr, Plant TM (2007) Effect
of continuous intravenous administration of human metastin 45-54 on the neuroendocrine
activity of the hypothalamic-pituitary-testicular axis in the adult male rhesus monkey (Macaca
mulatta). Endocrinology 148:3364-3370
51. George JT, Veldhuis JD, Roseweir AK, Newton CL, Faccenda E, Millar RP, Anderson RA
(2011) Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men. J Clin
Endocrinol Metab 96:E1228-1236
52. Chan YM, Butler JP, Sidhoum VF, Pinnell NE, Seminara SB (2012) Kisspeptin administration
to women: A window into endogenous kisspeptin secretion and GnRH responsiveness across
the menstrual cycle. J Clin Endocrinol Metab 97(8):E1458-67
53. Palczewski K, Buczylko J, Kaplan MW, Polans AS, Crabb JW (1991) Mechanism of rhodop-
sin kinase activation. J Biol Chem 266:12949-12955
54. Gurevich VV, Benovic JL (1993) Visual arrestin interaction with rhodopsin. Sequential multi-
site binding ensures strict selectivity toward light-activated phosphorylated rhodopsin. J Biol
Chem 268:11628-11638
55. Ferguson SS (2001) Evolving concepts in G protein-coupled receptor endocytosis: the role in
receptor desensitization and signaling. Pharmacol Rev 53:1-24
56. Drake MT, Shenoy SK, Lefkowitz RJ (2006) Traffi cking of G protein-coupled receptors. Circ
Res 99:570-582
57. Gurevich VV, Gurevich EV (2006) The structural basis of arrestin-mediated regulation of
G-protein-coupled receptors. Pharmacol Ther 110:465-502
58. Szereszewski JM, Pampillo M, Ahow MR, Offermanns S, Bhattacharya M, Babwah AV
(2010) GPR54 regulates ERK1/2 activity and hypothalamic gene expression in a Galpha(q/11)
and beta-arrestin-dependent manner. PLoS One 5:e12964
59. Chaturvedi K, Bandari P, Chinen N, Howells RD (2001) Proteasome involvement in agonist-
induced down-regulation of mu and delta opioid receptors. J Biol Chem 276:12345-12355
60. Shenoy SK, McDonald PH, Kohout TA, Lefkowitz RJ (2001) Regulation of receptor fate
by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin. Science 294:
1307-1313
61. Semple RK, Topaloglu AK (2010) The recent genetics of hypogonadotrophic hypogonad-
ism - novel insights and new questions. Clin Endocrinol (Oxf) 72:427-435
62. Sykiotis GP, Hoang XH, Avbelj M, Hayes FJ, Thambundit A, Dwyer A, Au M, Plummer L,
Crowley WF Jr, Pitteloud N (2010) Congenital idiopathic hypogonadotropic hypogonadism:
evidence of defects in the hypothalamus, pituitary, and testes. J Clin Endocrinol Metab
95:3019-3027
63. Pallais JC, Au M, Pitteloud N, Seminara S, Crowley WF (1993) Isolated gonadotropin-
releasing hormone (GnRH) defi ciency overview. In: Bird TD, Dolan CR, Stephens K, Adam
MP, Pagon RA (eds) GeneReviews™. University of Washington, Seattle
64. Cariboni A, Maggi R (2006) Kallmann's syndrome, a neuronal migration defect. Cell Mol Life
Sci 63:2512-2526
65. Mitchell AL, Dwyer A, Pitteloud N, Quinton R (2011) Genetic basis and variable phenotypic
expression of Kallmann syndrome: towards a unifying theory. Trends Endocrinol Metab
22:249-258
66. Bianco SD, Kaiser UB (2009) The genetic and molecular basis of idiopathic hypogonadotropic
hypogonadism. Nat Rev Endocrinol 5:569-576
67. Wahab F, Quinton R, Seminara SB (2011) The kisspeptin signaling pathway and its role in
human isolated GnRH defi ciency. Mol Cell Endocrinol 346:29-36
68. Wacker JL, Feller DB, Tang XB, Defi no MC, Namkung Y, Lyssand JS, Mhyre AJ, Tan X,
Jensen JB, Hague C (2008) Disease-causing mutation in GPR54 reveals the importance of the
second intracellular loop for class A G-protein-coupled receptor function. J Biol Chem
283:31068-31078
Search WWH ::




Custom Search